Alan G. Mnuchin - Aug 5, 2022 Form 4 Insider Report for Sharecare, Inc. (SHCR)

Role: Director
Signature: /s/Christie J. Miller, Attorney- in fact for the reporting person
Stock symbol: SHCR
Transactions as of: Aug 5, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/10/2022, 06:09 AM
Previous filing: Jun 24, 2022
Next filing: May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SHCR	Restricted Stock Units	Award	$0	+121K		$0.00	121K	Aug 5, 2022	Common Stock	121K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. The payment of such shares will be deferred in accordance with the Reporting Person's election pursuant to the Issuer's non-employee director deferral plan.
F2	The restricted stock units will vest on the earlier of (i) the next annual meeting of the Company's stockholders following the grant date and (ii) August 5, 2023, subject to the Reporting Person's continued service as a director of the Company.

Content

Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. The payment of such shares will be deferred in accordance with the Reporting Person's election pursuant to the Issuer's non-employee director deferral plan.

The restricted stock units will vest on the earlier of (i) the next annual meeting of the Company's stockholders following the grant date and (ii) August 5, 2023, subject to the Reporting Person's continued service as a director of the Company.